846 related articles for article (PubMed ID: 26017823)
1. Latent Mycobacterium tuberculosis infection.
Getahun H; Matteelli A; Chaisson RE; Raviglione M
N Engl J Med; 2015 May; 372(22):2127-35. PubMed ID: 26017823
[No Abstract] [Full Text] [Related]
2. Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
Daskalaki I; Byun J; Dogbey MC; Tolbert-Warren C; Watson BM
Pediatr Infect Dis J; 2011 Nov; 30(11):1014-5. PubMed ID: 21997666
[No Abstract] [Full Text] [Related]
3. Treatment of latent tuberculosis infection.
Parekh MJ; Schluger NW
Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
[TBL] [Abstract][Full Text] [Related]
4. Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
Chen YM; Liao TL; Chen HH; Chen DY
Ann Rheum Dis; 2018 Nov; 77(11):1688-1689. PubMed ID: 29674320
[No Abstract] [Full Text] [Related]
5. 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review.
Assefa Y; Assefa Y; Woldeyohannes S; Hamada Y; Getahun H
Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29748305
[TBL] [Abstract][Full Text] [Related]
6. Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan.
Sun HY; Huang YW; Huang WC; Chang LY; Chan PC; Chuang YC; Ruan SY; Wang JY; Wang JT
Tuberculosis (Edinb); 2018 Jul; 111():121-126. PubMed ID: 30029896
[TBL] [Abstract][Full Text] [Related]
7. Treatment of latent tuberculosis infection in HIV: shorter or longer?
Person AK; Sterling TR
Curr HIV/AIDS Rep; 2012 Sep; 9(3):259-66. PubMed ID: 22581360
[TBL] [Abstract][Full Text] [Related]
8. Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events.
Lin SY; Chiu YW; Lu PL; Hwang SJ; Chen TC; Hsieh MH; Chen YH
J Microbiol Immunol Infect; 2019 Feb; 52(1):158-162. PubMed ID: 29907535
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(48):1650-3. PubMed ID: 22157884
[TBL] [Abstract][Full Text] [Related]
10. Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates.
Simkins J; Morris MI; Abbo LM; Camargo JF
Transpl Int; 2017 Jan; 30(1):108-109. PubMed ID: 28032405
[No Abstract] [Full Text] [Related]
11. Treatment of latent tuberculosis infection.
Vernon A
Semin Respir Crit Care Med; 2013 Feb; 34(1):67-86. PubMed ID: 23460007
[TBL] [Abstract][Full Text] [Related]
12. Short-course isoniazid plus rifapentine therapy for latent tuberculosis in Brazil.
Croda J
Rev Soc Bras Med Trop; 2015; 48(5):505-6. PubMed ID: 26516957
[No Abstract] [Full Text] [Related]
13. Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice.
Fröberg G; Jansson L; Bruchfeld J
Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30409821
[No Abstract] [Full Text] [Related]
14. Updates in the Treatment of Active and Latent Tuberculosis.
Haas MK; Belknap RW
Semin Respir Crit Care Med; 2018 Jun; 39(3):297-309. PubMed ID: 30071545
[TBL] [Abstract][Full Text] [Related]
15. Question 1: what are the options for treating latent TB infection in children?
Gwee A; Coghlan B; Curtis N
Arch Dis Child; 2013 Jun; 98(6):468-74. PubMed ID: 23661667
[No Abstract] [Full Text] [Related]
16. New approaches to the treatment of latent tuberculosis.
Sterling TR
Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
[TBL] [Abstract][Full Text] [Related]
17. Latent Tuberculosis Infection.
Shah M; Dorman SE
N Engl J Med; 2021 Dec; 385(24):2271-2280. PubMed ID: 34879450
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of treating latent tuberculous infection: a step towards elimination?
Diel R; Loddenkemper R; Sotgiu G; Migliori GB
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1515. PubMed ID: 24200259
[No Abstract] [Full Text] [Related]
19. Evaluation of 3 Months of Once-Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection.
Walker RE; Bass S; Srinivas P; Miranda C; Johnson L; Pallotta AM
Ann Pharmacother; 2020 May; 54(5):457-463. PubMed ID: 31729245
[No Abstract] [Full Text] [Related]
20. Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population.
Jiménez-Fuentes MA; de Souza-Galvao ML; Mila Augé C; Solsona Peiró J; Altet-Gómez MN
Int J Tuberc Lung Dis; 2013 Mar; 17(3):326-32. PubMed ID: 23407221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
